Hepatic Effects of Chlorpropamide: Inhibition of Glucagon-stimulated Gluconeogenesis in Perfused Livers of Fasted Rats

In perfused livers of rats fasted for 24 h, glucagon (5 × 10−10 M) significantly elevated tissue and perfusate levels of cyclic AMP and caused a twofold increase in glucose formation from lactate. Chlorpropamide (0.8 × 10−3 M) consistently blocked these effects. Measurements of metabolic intermediates suggest that chlorpropamide may inhibit gluconeogenesis by antagonizing the action of glucagon on the phosphoenolpyruvate cycle. In the experiments described, chlorpropamide did not lower hepatic ATP concentration or energy charge, and exerted its effects at perfusate concentrations comparable to serum concentrations reported in patients on maintenance doses of the drug.

[1]  O. Wieland,et al.  Glucagon‐induced stimulation of 2‐oxoglutarate metabolism in mitochondria from rat liver , 1978, FEBS letters.

[2]  J. B. Blair,et al.  Acute hormonal control of pyruvate kinase and lactate formation in the isolated rat hepatocyte. , 1978, Archives of biochemistry and biophysics.

[3]  A. Halestrap.  Stimulation of pyruvate transport in metabolizing mitochondria through changes in the transmembrane pH gradient induced by glucagon treatment of rats. , 1978, The Biochemical journal.

[4]  J. Riou,et al.  Stimulation of glucagon of in vivo phosphorylation of rat hepatic pyruvate kinase. , 1978, The Journal of biological chemistry.

[5]  G. Sartor,et al.  Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus , 1978, British medical journal.

[6]  J. K. Kruijt,et al.  Hormone‐Induced Changes in Pyruvate Kinase , 1977 .

[7]  S. Blumenthal.  Potentiation of the Hepatic Action of Insulin by Chlorpropamide , 1977, Diabetes.

[8]  E. Tsalikian,et al.  The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal , 1977, Diabetes.

[9]  J. Katz,et al.  Role of pyruvate kinase in the regulation of gluconeogenesis from L-lactate. , 1977, The Journal of biological chemistry.

[10]  G. Mannaerts,et al.  Effect of sulfonylureas on triglyceride metabolism in the rat liver: possible role of the lysosomes in hepatic lipolysis. , 1977, The Journal of clinical investigation.

[11]  J. E. Felíu,et al.  Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. B. Blair,et al.  Hepatic pyruvate kinase. Regulation by glucagon, cyclic adenosine 3'-5'-monophosphate, and insulin in the perfused rat liver. , 1976, The Journal of biological chemistry.

[13]  R. H. Bowman,et al.  Excretion and degradation of exogenous adenosine 3',5'-monophosphate by isolated perfused rat kidney. , 1974, Life sciences.

[14]  A. Gilman.  A protein binding assay for adenosine 3':5'-cyclic monophosphate. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Haynes,et al.  Control of hepatic mitochondrial CO2 fixation by glucagon, epinephrine, and cortisol. , 1969, The Journal of biological chemistry.

[16]  D. E. Atkinson.  The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. , 1968, Biochemistry.

[17]  T. V. van Berkel,et al.  Hormone-induced changes in pyruvate kinase. Effects of glucagon and starvation. , 1977, European journal of biochemistry.

[18]  J. Katz,et al.  Futile cycles in the metabolism of glucose. , 1976, Current topics in cellular regulation.

[19]  G. Reaven,et al.  Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. , 1976, The American journal of medicine.

[20]  J. Exton.  The perfused rat liver. , 1975, Methods in enzymology.

[21]  P. Foà,et al.  Diurnal variations of serum insulin, total glucagon, cortisol, glucose and free fatty acids in normal and diabetic subjects before and after treatment with chlorpropamide. , 1974, Hormone research.